RO 091227
Alternative Names: RO 91227; SR 1024Latest Information Update: 17 Jul 2000
At a glance
- Originator Roche
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 17 Jul 2000 Discontinued-Preclinical for Bacterial infections in Switzerland (Unknown route)
- 16 Jan 1995 Preclinical development for Bacterial infections in Switzerland (Unknown route)